Cargando…

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii

PURPOSE: To study the in vitro and in vivo antibacterial activities of polymyxin B (PB) and other five antimicrobial agents, including imipenem (IMP), meropenem (MEM), tigecycline (TGC), sulbactam (SUL), and rifampicin (RIF), alone or in combination against carbapenem-resistant Acinetobacter baumann...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hui, Zhu, Yunzhu, Yang, Ning, Kong, Qinxiang, Zheng, Yahong, Lv, Na, Chen, Haoran, Yue, Chengcheng, Liu, Yanyan, Li, Jiabin, Ye, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577563/
https://www.ncbi.nlm.nih.gov/pubmed/34764660
http://dx.doi.org/10.2147/IDR.S334200
_version_ 1784596085525708800
author Zhang, Hui
Zhu, Yunzhu
Yang, Ning
Kong, Qinxiang
Zheng, Yahong
Lv, Na
Chen, Haoran
Yue, Chengcheng
Liu, Yanyan
Li, Jiabin
Ye, Ying
author_facet Zhang, Hui
Zhu, Yunzhu
Yang, Ning
Kong, Qinxiang
Zheng, Yahong
Lv, Na
Chen, Haoran
Yue, Chengcheng
Liu, Yanyan
Li, Jiabin
Ye, Ying
author_sort Zhang, Hui
collection PubMed
description PURPOSE: To study the in vitro and in vivo antibacterial activities of polymyxin B (PB) and other five antimicrobial agents, including imipenem (IMP), meropenem (MEM), tigecycline (TGC), sulbactam (SUL), and rifampicin (RIF), alone or in combination against carbapenem-resistant Acinetobacter baumannii (CRAB). METHODS: Microbroth dilution method was used to determine the minimum inhibitory concentration (MIC) of ten strains of CRAB against six antibacterial drugs, and the checkerboard method was used to determine the fractional inhibitory concentration index (FICI). A mouse pneumonia model was established by intranasal instillation of Ab5075 to evaluate the antibacterial activity in vivo. RESULTS: The resistance rate of ten CRAB strains to IMP, MEM, and SUL was 100%, that to PB and TGC was 0%, and that to RIF was 20%. When PB was used in combination with the other five antibiotics in vitro, it mainly showed synergistic and additive effects on CRAB. The synergistic effect of PB and RIF was maximal, followed by MEM and IMP but was weak with SUL and TGC. In vivo, compared to the model group (untreated with antibiotics), treatment group (six antibiotics alone and PB combined with the other five antibiotics) reduced the bacterial load in the lung tissue and the serum inflammatory factors (IL-1β, IL-6, and TNF-α). The bacterial load and the inflammatory factors of the combined group decreased significantly than that of the single group (P<0.05). The IL-6 and TNF-α values of the PB combined with the RIF group were significantly lower than the two drugs used individually. CONCLUSION: The combination of PB and IMP, MEM, and RIF exerted robust in vitro synergistic effects on CRAB isolates. The combination of PB and the other five antimicrobial agents had a better effect in the mouse pneumonia model than single agent, while the combination of PB and RIF had the best effect.
format Online
Article
Text
id pubmed-8577563
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85775632021-11-10 In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii Zhang, Hui Zhu, Yunzhu Yang, Ning Kong, Qinxiang Zheng, Yahong Lv, Na Chen, Haoran Yue, Chengcheng Liu, Yanyan Li, Jiabin Ye, Ying Infect Drug Resist Original Research PURPOSE: To study the in vitro and in vivo antibacterial activities of polymyxin B (PB) and other five antimicrobial agents, including imipenem (IMP), meropenem (MEM), tigecycline (TGC), sulbactam (SUL), and rifampicin (RIF), alone or in combination against carbapenem-resistant Acinetobacter baumannii (CRAB). METHODS: Microbroth dilution method was used to determine the minimum inhibitory concentration (MIC) of ten strains of CRAB against six antibacterial drugs, and the checkerboard method was used to determine the fractional inhibitory concentration index (FICI). A mouse pneumonia model was established by intranasal instillation of Ab5075 to evaluate the antibacterial activity in vivo. RESULTS: The resistance rate of ten CRAB strains to IMP, MEM, and SUL was 100%, that to PB and TGC was 0%, and that to RIF was 20%. When PB was used in combination with the other five antibiotics in vitro, it mainly showed synergistic and additive effects on CRAB. The synergistic effect of PB and RIF was maximal, followed by MEM and IMP but was weak with SUL and TGC. In vivo, compared to the model group (untreated with antibiotics), treatment group (six antibiotics alone and PB combined with the other five antibiotics) reduced the bacterial load in the lung tissue and the serum inflammatory factors (IL-1β, IL-6, and TNF-α). The bacterial load and the inflammatory factors of the combined group decreased significantly than that of the single group (P<0.05). The IL-6 and TNF-α values of the PB combined with the RIF group were significantly lower than the two drugs used individually. CONCLUSION: The combination of PB and IMP, MEM, and RIF exerted robust in vitro synergistic effects on CRAB isolates. The combination of PB and the other five antimicrobial agents had a better effect in the mouse pneumonia model than single agent, while the combination of PB and RIF had the best effect. Dove 2021-11-05 /pmc/articles/PMC8577563/ /pubmed/34764660 http://dx.doi.org/10.2147/IDR.S334200 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Hui
Zhu, Yunzhu
Yang, Ning
Kong, Qinxiang
Zheng, Yahong
Lv, Na
Chen, Haoran
Yue, Chengcheng
Liu, Yanyan
Li, Jiabin
Ye, Ying
In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
title In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
title_full In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
title_fullStr In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
title_full_unstemmed In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
title_short In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
title_sort in vitro and in vivo activity of combinations of polymyxin b with other antimicrobials against carbapenem-resistant acinetobacter baumannii
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577563/
https://www.ncbi.nlm.nih.gov/pubmed/34764660
http://dx.doi.org/10.2147/IDR.S334200
work_keys_str_mv AT zhanghui invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT zhuyunzhu invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT yangning invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT kongqinxiang invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT zhengyahong invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT lvna invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT chenhaoran invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT yuechengcheng invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT liuyanyan invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT lijiabin invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii
AT yeying invitroandinvivoactivityofcombinationsofpolymyxinbwithotherantimicrobialsagainstcarbapenemresistantacinetobacterbaumannii